rivastigmine has been researched along with Neurodegenerative Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolognesi, ML; Cavalli, A; Melchiorre, C; Minarini, A; Recanatini, M; Rosini, M; Tumiatti, V | 1 |
| Majidazar, R; Naseri, A; Rezazadeh-Gavgani, E; Sadigh-Eteghad, S | 1 |
| Borges, F; Brunetti, L; Cardoso, SM; Chavarria, D; Chaves, S; Guedes, B; Madrid, Y; Piemontese, L; Santos, MA; Vicente-Zurdo, D | 1 |
| Ahmad, F; Hassan, MI; Husain, FM; Islam, A; Khan, MS; Mohammad, T; Rehman, MT; Shahwan, M; Shamsi, A | 1 |
| Cummings, JL; Ringman, JM | 1 |
3 review(s) available for rivastigmine and Neurodegenerative Diseases
| Article | Year |
|---|---|
Multi-target-directed ligands to combat neurodegenerative diseases.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Binding Sites; Calcium Channel Blockers; Chelating Agents; Cholinesterase Inhibitors; Humans; Huntington Disease; Ligands; Multiple Sclerosis; Neurodegenerative Diseases; Neurofibrillary Tangles; Neurotransmitter Agents; Parkinson Disease; Plaque, Amyloid | 2008 |
Pharmacotherapy of Alzheimer's disease: an overview of systematic reviews.
Topics: Alzheimer Disease; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Cholinesterase Inhibitors; Donepezil; Galantamine; Glycogen Synthase Kinase 3; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Indans; Lithium; Melatonin; Memantine; Neurodegenerative Diseases; Rivastigmine; Systematic Reviews as Topic | 2022 |
Current and emerging pharmacological treatment options for dementia.
Topics: Acetylcholine; Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Donepezil; Galantamine; Humans; Indans; Lewy Body Disease; Neurodegenerative Diseases; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Piperidines; Rivastigmine; Tacrine | 2006 |
2 other study(ies) available for rivastigmine and Neurodegenerative Diseases
| Article | Year |
|---|---|
Rivastigmine-Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Benzimidazoles; Chelating Agents; Cholinesterase Inhibitors; Ferric Compounds; Humans; Monoamine Oxidase; Neuroblastoma; Neurodegenerative Diseases; Rivastigmine | 2023 |
Unraveling Binding Mechanism of Alzheimer's Drug Rivastigmine Tartrate with Human Transferrin: Molecular Docking and Multi-Spectroscopic Approach towards Neurodegenerative Diseases.
Topics: Binding Sites; Calorimetry; Circular Dichroism; Humans; Hydrogen Bonding; Models, Molecular; Molecular Docking Simulation; Neurodegenerative Diseases; Protein Binding; Protein Conformation; Rivastigmine; Spectrometry, Fluorescence; Thermodynamics; Transferrin | 2019 |